You are here

KaloBios offered financing in plan to buy drug for Chagas disease

Black Horse Capital offered to buy at least 40% of KaloBios for US$10 million on condition Martin Shkreli (above) holds no more than 20% of the company's voting shares


KALOBIOS Pharmaceuticals Inc, the drug company that plunged into bankruptcy after the arrest of its former chief executive officer Martin Shkreli, is getting some help for its plan to buy a treatment for Chagas disease.

Hedge fund Black Horse Capital LP offered to buy at

Market voices on:

Powered by GET.comGetCom